Literature DB >> 11740046

Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate.

R V Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11740046     DOI： 10.1385/ep:12:3:255

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN： 1046-3976            Impact factor:   3.943


× No keyword cloud information.
  19 in total

1.  Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.

Authors:  Z W Baloch; S Abraham; S Roberts; V A LiVolsi
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

2.  Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

Authors:  Y E Nikiforov; J M Rowland; K E Bove; H Monforte-Munoz; J A Fagin
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

3.  Retinoblastoma expression in thyroid neoplasms.

Authors:  F Anwar; M J Emond; R A Schmidt; H C Hwang; M P Bronner
Journal:  Mod Pathol       Date:  2000-05       Impact factor: 7.842

4.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 5.  Galectins. Structure and function of a large family of animal lectins.

Authors:  S H Barondes; D N Cooper; M A Gitt; H Leffler
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

Review 6.  Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.

Authors:  A Raz; R Lotan
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.

Authors:  A Bartolazzi; A Gasbarri; M Papotti; G Bussolati; T Lucante; A Khan; H Inohara; F Marandino; F Orlandi; F Nardi; A Vecchione; R Tecce; O Larsson
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

8.  Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer.

Authors:  C C Cheung; B Carydis; S Ezzat; Y C Bedard; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

9.  Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.

Authors:  P L Fernández; M J Merino; M Gómez; E Campo; T Medina; V Castronovo; X Sanjuán; A Cardesa; F T Liu; M E Sobel
Journal:  J Pathol       Date:  1997-01       Impact factor: 7.996

10.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

Authors:  X C Xu; A K el-Naggar; R Lotan
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307
View more
  4 in total

1.  The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions.

Authors:  E Raggio; M Camandona; D Solerio; P Martino; A Franchello; F Orlandi; G Gasparri
Journal:  J Endocrinol Invest       Date:  2009-07-21       Impact factor: 4.256

2.  Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.

Authors:  Barbara Cecchinelli; Luca Lavra; Cinzia Rinaldo; Stefano Iacovelli; Aymone Gurtner; Alessandra Gasbarri; Alessandra Ulivieri; Fabrizio Del Prete; Maria Trovato; Giulia Piaggio; Armando Bartolazzi; Silvia Soddu; Salvatore Sciacchitano
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.

Authors:  E Saggiorato; S Aversa; D Deandreis; F Arecco; A Mussa; B Puligheddu; S Cappia; S Conticello; M Papotti; F Orlandi
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

4.  Galectins as cancer biomarkers.

Authors:  Vitaly Balan; Pratima Nangia-Makker; Avraham Raz
Journal:  Cancers (Basel)       Date:  2010-04-20       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.